here is where we are at

after speaking to director this morning,this is where we are at
1.fda will not be lodged until mexico first delivery is done
2.the reason is hgr cannot export to mexico if it lodges fda approval,it must export first batch first,then lodge fda approval,otherwise it cannot export while waiting for fda approval
3.this will be finalised over the next couple of days
4.he has been in poland discussing a new company to take over selling hgr ovaline into russia and czech republic due to increasing drug problem there
4.this will beat no cost to hgr as it will be a company purchasing from hgr to sell there
5.everything is going according to their strategy and are looking forward to a very good yr
6.i am very confident after this mornings discussions